I thought the presentation was a good illustration of the new directions at CAA since 2008. Finally someone understands how to apply a 'systems biology' viewpoint to address the multi-systemic complexity of CFS!
Every study seems important, like they have narrowed to focus to studies they know can find something, no prospecting here, these are bread and butter efforts that should change the face of CFS diagnostics. One annoyance, everyone keeps talking about biomarkers, what is up with that? I just can't fathom why this myth persists that there is some great need for biomarkers for CFS. We have abundant biomarkers, have had some for over 20 years. What we need is good differential diagnostics. This was about research into better diagnostics, in my view. Some of these studies may also help with subset determination, as Dr Vernon mentioned near the end. Also, every study seems posed to reveal something new about CFS. The CAA is getting a lot of value for their investment here. Impressive. This is what we need, and a lot more of this type of effort.
Listening to this I could sense more than ever the reality of CFS as a complex multi-systemic disease with a profile as real as any other disease out there. A real class act, particularly the final study, a database of all CFS research, it is about time!